Related Experiment Video
Updated: Jul 19, 2026
07:50
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cell therapy after myocardial infarction: ready for clinical application?
Markus G Engelmann1, Wolfgang M Franz
1Medical Department I-Cardiology, Ludwig Maximilians University, Klinikum Grosshadern, Marchioninistr 15, 81377 Munich, Germany.
Current Opinion in Molecular Therapeutics
|November 3, 2006
Summary
Adult stem cells, or
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Stem cells offer potential treatments for heart disease.
- Embryonic stem cells show promise for regenerative medicine and tissue engineering.
- Mechanisms of stem cell therapy for heart repair are not fully understood.
Purpose of the Study:
- To review the use of adult human stem cells for treating myocardial infarction and cardiomyopathy.
- To discuss preliminary efficacy data of stem cell therapy in cardiac repair.
- To explore the potential of 'regenerator cells' in improving heart function.
Main Methods:
- Review of current literature on adult stem cell applications in cardiology.
- Analysis of studies on stem cell delivery and mobilization for cardiac repair.
- Discussion of safety and efficacy data from clinical trials.
Main Results:
- Adult stem cells, acting as 'regenerator cells', may improve myocardial perfusion and function.
- Hematopoietic stem cells are safe for myocardial infarction and cardiomyopathies.
- Skeletal myoblasts carry risks of arrhythmias.
Conclusions:
- Adult stem cells show potential for improving cardiac perfusion and contractile performance.
- Further research is needed to elucidate the mechanisms of stem cell therapy.
- Stem cell therapy holds promise for patients with heart failure and ischemic heart disease.
